🫁 Case Study on Chronic Obstructive Pulmonary Disease (COPD)

Medical-Surgical Nursing | NANDA Nursing Care Plan Format

Respiratory Nursing | Practical File Ready

📋 Student Information

📄 Page 1 — Patient Identification Data

📄 Page 2 — Chief Complaints & Clinical History

CHIEF COMPLAINT

The patient was brought to the emergency department at 9:15 PM with the complaints of:

• Severe shortness of breath since 2 days, increased markedly since morning
• Productive cough with thick yellowish sputum since 5 days
• Wheezing and chest tightness since 3 days
• Fever with chills since 2 days
• Unable to sleep in lying position; prefers sitting upright
• Marked fatigue and inability to perform daily activities
• Loss of appetite and generalized weakness
• History of recurrent similar episodes for the last 4 years

HISTORY OF PRESENT ILLNESS

The patient, Mr. Mohan Lal Sharma, a 68-year-old retired textile mill worker, was apparently living with chronic breathlessness and cough for the last 8 years. He had progressive exertional dyspnea, initially occurring only during heavy work, but gradually increasing over the years. For the last 2 years, he developed breathlessness even while walking inside the house and climbing a few steps. He also had chronic cough with mucoid sputum, especially in the early morning.

Five days before admission, the patient developed increased cough with thick yellowish sputum. Three days before admission, he developed wheezing, chest tightness, and increased breathlessness. Two days before admission, he developed low-grade fever with chills and malaise. On the day of admission, breathlessness became severe even at rest. He was unable to speak full sentences and had to sit leaning forward to breathe. Family members noticed bluish discoloration of lips and excessive drowsiness. He was brought to the emergency department by his son.

On arrival, the patient was conscious but drowsy, dyspneic, tachypneic, using accessory muscles of respiration, and had oxygen saturation of 82% on room air. Auscultation revealed bilateral diffuse wheeze with coarse crepitations. Arterial blood gas analysis showed hypoxemia with hypercapnia, suggestive of Type II respiratory failure. The patient was immediately started on controlled oxygen therapy, nebulization with bronchodilators, IV corticosteroids, antibiotics, and non-invasive ventilation support. He was admitted to the Respiratory Medicine HDU for close monitoring and management.

PAST MEDICAL HISTORY

• Known case of COPD for 8 years; diagnosed by spirometry showing persistent airflow limitation
• History of recurrent acute exacerbations requiring hospitalization 2 times in the last 1 year
• Hypertension — diagnosed 10 years ago; on Tablet Amlodipine 5mg OD
• No known history of diabetes mellitus, tuberculosis, bronchial asthma, epilepsy, or ischemic heart disease
• History of frequent respiratory infections during winter season
• No known drug allergy

PAST SURGICAL HISTORY

• No history of any major surgical intervention.
• No history of thoracic surgery or lung biopsy.
• No history of blood transfusion.

📄 Page 3 — Family History & Composition

FAMILY HISTORY

• The patient belongs to a joint family.
• There are 6 members in the family — patient, wife, son, daughter-in-law, and 2 grandchildren.
• Father — chronic smoker; died at age 72 due to chronic respiratory illness.
• Mother — died at age 78 due to age-related illness.
• No family history of bronchial asthma, tuberculosis, lung cancer, or genetic lung disease reported.
• Son is healthy but occasionally smokes; family was advised regarding passive smoking risk.
• Environmental and smoking-related respiratory risk is present in the family.

FAMILY COMPOSITION

FAMILY TREE

📄 Page 4 — Dietary, Personal, Socio-Economic & Environmental History

DIETARY HISTORY

• The patient takes a mixed diet, mainly vegetarian with occasional non-vegetarian food.
• Appetite is reduced since the present illness due to breathlessness and fatigue.
• Diet is low in protein and calories; patient often avoids full meals because eating increases dyspnea.
• Consumes tea 4-5 times/day and takes spicy fried snacks frequently.
• Fluid intake is approximately 1.5-2 liters/day.
• No known food allergy reported.
• Patient has mild weight loss over the last 6 months due to chronic illness and poor appetite.

PERSONAL HISTORY

• Sleep: Disturbed sleep due to cough, wheezing, and breathlessness; sleeps with 2 pillows.
• Appetite: Reduced during exacerbation.
• Bowel: Once daily, occasionally constipated due to reduced activity and low fiber intake.
• Bladder: Normal frequency; no burning micturition.
• Habits: Chronic smoker for 40 years — approximately 15 cigarettes/day; stopped smoking irregularly but restarted several times.
• Occupational exposure: Worked in textile mill for 30 years with exposure to cotton dust and industrial fumes.
• Activity level: Markedly reduced; gets breathless while walking short distance.
• Allergy: No known drug or food allergy.
• BMI: 20.1 kg/m² — borderline low normal with muscle wasting.

SOCIO-ECONOMIC HISTORY

• The patient belongs to a lower-middle-class family.
• Family income is mainly from son's shop and patient's small pension.
• Patient lives in a joint family and receives good family support.
• Financial limitations affect regular follow-up and purchase of inhalers.
• Patient has access to government hospital services.

ENVIRONMENTAL HISTORY

• The family lives in a pucca house with moderate ventilation.
• Patient is exposed to dust due to nearby road traffic and dry climate.
• Uses LPG for cooking; no biomass fuel exposure currently.
• Past occupational exposure to textile dust is significant.
• Safe drinking water and sanitation facilities are available.
• Family was advised to keep the home smoke-free and dust-free.

📄 Page 5 & 6 — Physical Examination

GENERAL CONDITION

Patient is conscious but drowsy, oriented to person and place, dyspneic, and appears exhausted. He is sitting in tripod position, using accessory muscles of respiration. Speech is broken due to breathlessness. Patient appears anxious and fatigued.

VITAL SIGNS

• Temperature: 100.4°F
• Pulse: 112 beats/min
• Respiration: 32 breaths/min
• Blood Pressure: 150/90 mmHg
• SpO₂: 82% on room air; 90% with controlled oxygen
• Pain Score: 2/10 — chest tightness, no severe chest pain

GENERAL APPEARANCE

• Built: Thin, mildly wasted appearance
• Posture: Tripod position; leaning forward to breathe
• Activity: Severely limited due to dyspnea
• Speech: Unable to complete full sentences
• Signs of distress: Tachypnea, nasal flaring, pursed-lip breathing, use of accessory muscles
• Skin: Mild central cyanosis present; skin warm due to fever
• Chest shape: Barrel-shaped chest suggestive of chronic hyperinflation

SYSTEMIC EXAMINATION

📄 Page 7 — Vital Signs Monitoring Record

📄 Page 8 — Diagnostic Investigations

📄 Page 9 — Medical Management (Drug Chart)

📄 Page 10 — Disease Introduction, Etiology & Pathophysiology

INTRODUCTION

Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable, and treatable chronic respiratory disease characterized by persistent airflow limitation that is usually progressive and associated with chronic inflammatory response in the airways and lungs. The airflow limitation is not fully reversible and is mainly caused by chronic bronchitis, emphysema, or a combination of both.

COPD develops gradually over many years. The most common cause is long-term exposure to harmful particles or gases, especially cigarette smoke. Other important causes include occupational dust exposure, air pollution, biomass fuel smoke, and recurrent respiratory infections. COPD mainly affects middle-aged and elderly people and is a major cause of morbidity, repeated hospitalization, disability, and mortality worldwide.

In this case, the patient is a 68-year-old male with a long history of smoking and occupational exposure to textile dust. He presented with acute worsening of breathlessness, productive cough, wheezing, fever, hypoxemia, and hypercapnia. These features suggest acute exacerbation of COPD with Type II respiratory failure.

ETIOLOGY

The main etiological factors responsible for COPD in this patient are:

• Cigarette smoking: The patient has a 40-year history of smoking approximately 15 cigarettes per day. Smoking causes chronic airway inflammation, mucus gland enlargement, ciliary dysfunction, airway narrowing, and destruction of alveolar walls.
• Occupational exposure: Long-term exposure to cotton dust and industrial fumes in textile mill work contributed to chronic airway irritation and inflammation.
• Air pollution and dust exposure: Living in a dusty environment and exposure to traffic-related pollution may aggravate respiratory symptoms.
• Recurrent respiratory infections: Frequent infections cause repeated airway inflammation and accelerate decline in lung function.
• Age-related lung changes: Elderly age reduces lung elasticity and respiratory reserve.
• Poor treatment adherence: Irregular inhaler use and delayed follow-up increase the risk of exacerbation.
• Nutritional weakness: Reduced appetite and weight loss reduce respiratory muscle strength.

PATHOPHYSIOLOGY

The pathophysiology of COPD involves chronic inflammation of the airways, lung parenchyma, and pulmonary blood vessels due to prolonged exposure to harmful particles such as cigarette smoke and occupational dust.

1. Chronic Airway Inflammation: Inhaled irritants activate inflammatory cells such as neutrophils, macrophages, and CD8+ T lymphocytes. These cells release inflammatory mediators, proteolytic enzymes, and oxidative substances. This leads to edema of bronchial mucosa, thickening of airway walls, and narrowing of small airways.

2. Mucus Hypersecretion: Chronic irritation causes hypertrophy of mucus glands and increase in goblet cells. Excess thick mucus is produced. Ciliary function is impaired due to smoking, so mucus clearance becomes poor. Accumulated secretions obstruct airways and provide a medium for bacterial growth, causing recurrent infections.

3. Bronchoconstriction and Airway Obstruction: Inflammation and mucus plugging narrow the bronchial lumen. During expiration, small airways collapse early due to loss of elastic support. This causes air trapping and incomplete emptying of lungs.

4. Emphysematous Changes: Protease-antiprotease imbalance and oxidative stress destroy alveolar walls. Alveoli become enlarged and lose elasticity. The surface area for gas exchange decreases. Loss of elastic recoil makes expiration difficult and causes hyperinflation of lungs.

5. Ventilation-Perfusion Mismatch: Some lung areas are poorly ventilated due to obstruction, while blood flow continues. This causes reduced oxygenation of blood, resulting in hypoxemia. In advanced COPD, CO₂ elimination is also impaired, causing hypercapnia.

6. Respiratory Acidosis: Retention of carbon dioxide increases carbonic acid in blood, lowering pH. In chronic COPD, kidneys compensate by retaining bicarbonate, but during acute exacerbation compensation becomes insufficient, leading to acute-on-chronic respiratory acidosis.

7. Increased Work of Breathing: Air trapping and hyperinflation flatten the diaphragm. Respiratory muscles must work harder. Patient uses accessory muscles and adopts tripod position to improve ventilation. Prolonged increased work of breathing leads to fatigue and respiratory failure.

8. Pulmonary Hypertension and Cor Pulmonale: Chronic hypoxemia causes pulmonary vasoconstriction. Over time, pulmonary artery pressure increases and right ventricle becomes strained. This may lead to right-sided heart failure, known as cor pulmonale.

📄 Page 11 — Clinical Manifestations, Diagnostic & Medical Management

CLINICAL MANIFESTATIONS

The patient presented with classical features of acute exacerbation of COPD:

• Progressive dyspnea: Breathlessness increased from exertional dyspnea to dyspnea at rest. Patient was unable to speak full sentences.
• Chronic productive cough: Long-standing cough with increased sputum production during exacerbation.
• Purulent sputum: Thick yellowish sputum indicates infective exacerbation.
• Wheezing: Diffuse wheeze due to bronchospasm and narrowed airways.
• Chest tightness: Due to bronchoconstriction and hyperinflation.
• Fever and chills: Suggest respiratory infection as a trigger for exacerbation.
• Pursed-lip breathing: Patient uses this technique naturally to prevent airway collapse during expiration.
• Tripod position: Sitting forward helps accessory muscles work better and reduces respiratory distress.
• Cyanosis: Bluish discoloration of lips and nail beds due to hypoxemia.
• Drowsiness and confusion: Due to hypercapnia and CO₂ retention.
• Fatigue and weakness: Due to increased work of breathing, poor oxygenation, and reduced nutritional status.
• Barrel-shaped chest: Due to chronic hyperinflation and air trapping.

DIAGNOSTIC EVALUATION

• Arterial Blood Gas Analysis: pH 7.31, PaCO₂ 62 mmHg, PaO₂ 54 mmHg, HCO₃⁻ 30 mEq/L. These values indicate acute-on-chronic Type II respiratory failure with respiratory acidosis and partial metabolic compensation.
• Pulse Oximetry: SpO₂ 82% on room air, improved to 90-94% with controlled oxygen therapy.
• Chest X-Ray: Hyperinflated lungs, flattened diaphragm, increased bronchovascular markings. These findings support COPD with chronic hyperinflation.
• Spirometry: FEV₁/FVC ratio 48% and FEV₁ 42% predicted, showing severe obstructive airway disease.
• Complete Blood Count: WBC count 15,600/mm³ with neutrophilia, suggestive of bacterial infection.
• Sputum Examination: Purulent sputum with organisms seen on microscopy; culture sent for antibiotic sensitivity.
• Serum Electrolytes: Potassium slightly low, requiring monitoring because beta-agonist nebulization may further reduce potassium level.
• ECG: Sinus tachycardia; no acute ischemic changes. ECG helps rule out cardiac cause of breathlessness.

MEDICAL MANAGEMENT

• Controlled Oxygen Therapy: Oxygen was administered carefully using nasal prongs/Venturi mask to maintain target SpO₂ around 88-92% initially. Excess oxygen in CO₂ retainers can worsen hypercapnia; therefore oxygen therapy was controlled and monitored with ABG.
• Non-Invasive Ventilation: BiPAP was used because patient had hypercapnia, respiratory acidosis, severe dyspnea, and accessory muscle use. NIV improves alveolar ventilation, reduces PaCO₂, decreases respiratory muscle fatigue, and reduces need for intubation.
• Bronchodilator Therapy: Nebulized Salbutamol and Ipratropium Bromide were given regularly. These medications relieve bronchospasm, open airways, reduce wheeze, and improve airflow.
• Corticosteroid Therapy: IV Hydrocortisone followed by oral Prednisolone was given to reduce airway inflammation, shorten recovery time, and improve lung function during exacerbation.
• Antibiotic Therapy: Ceftriaxone and Azithromycin were prescribed because the patient had fever, increased sputum volume, purulent sputum, and raised WBC count, suggesting infective exacerbation.
• Chest Physiotherapy: Deep breathing exercises, coughing techniques, postural drainage as tolerated, and chest percussion were used to mobilize secretions.
• Hydration and Nutrition: Adequate oral fluids, high-calorie and high-protein diet in small frequent meals were advised to maintain energy and reduce fatigue during eating.
• Smoking Cessation: Patient and family were counseled strictly to stop smoking and avoid passive smoke exposure.

📄 Page 12 — Nursing Management, Health Education, Prognosis & Conclusion

NURSING MANAGEMENT

Nursing management of COPD with acute exacerbation focuses on maintaining airway patency, improving ventilation and oxygenation, reducing work of breathing, preventing complications, promoting secretion clearance, supporting nutrition, reducing anxiety, and educating the patient and family for long-term home care.

• Airway and Breathing Assessment: Assessed respiratory rate, rhythm, depth, use of accessory muscles, nasal flaring, chest expansion, breath sounds, cough effectiveness, sputum amount, color, consistency, and oxygen saturation. Patient was observed for signs of respiratory fatigue such as drowsiness, shallow breathing, silent chest, and inability to cough effectively.
• Positioning: Patient was kept in high Fowler's position and encouraged to sit in tripod position during severe dyspnea. This position improves diaphragmatic movement, decreases pressure on lungs, promotes lung expansion, and reduces work of breathing.
• Controlled Oxygen Administration: Oxygen was administered as prescribed through nasal prongs/Venturi mask. SpO₂ was monitored continuously and ABG was repeated as advised. Excessive oxygen was avoided because COPD patients with CO₂ retention may develop worsening hypercapnia.
• Monitoring During NIV/BiPAP: Patient was supported during non-invasive ventilation. Mask fitting, skin pressure areas, air leak, patient comfort, respiratory effort, mental status, and SpO₂ were monitored. Patient was reassured to reduce fear of mask ventilation.
• Nebulization Care: Nebulized Salbutamol and Ipratropium were administered as prescribed. Pulse rate, tremors, palpitations, potassium level, and response to bronchodilator therapy were monitored. Nebulizer chamber and mask were kept clean to prevent infection.
• Medication Administration: IV antibiotics, corticosteroids, antipyretics, antihypertensive drugs, and gastric protection medicines were administered on time. Patient was monitored for side effects such as steroid-induced hyperglycemia, gastric irritation, secondary infection, and antibiotic allergy.
• Airway Clearance Measures: Patient was encouraged to perform effective coughing, huff coughing, deep breathing exercises, and pursed-lip breathing. Chest physiotherapy and postural drainage were provided as tolerated. Adequate hydration was encouraged to loosen secretions unless contraindicated.
• Sputum Observation: Sputum amount, color, odor, and consistency were monitored. Thick yellow sputum was reported to physician. Sputum sample was collected in a sterile container before antibiotics whenever possible.
• Infection Control: Hand hygiene, respiratory hygiene, proper disposal of sputum, use of mask during coughing, and clean nebulization equipment were maintained. Visitors with respiratory infection were restricted.
• Energy Conservation: Nursing care activities were planned with rest periods. Patient was assisted with bathing, toileting, and feeding during acute dyspnea. Unnecessary exertion was avoided. Gradual mobilization was started after improvement.
• Nutritional Support: Small frequent high-calorie and high-protein meals were advised. Patient was encouraged to rest before meals and eat slowly. Gas-forming foods and heavy meals were avoided because abdominal distension can increase breathlessness.
• Anxiety Reduction: Patient was reassured calmly. Procedures were explained in simple language. Family presence was allowed as per hospital policy. Relaxation breathing and pursed-lip breathing were taught to reduce panic during dyspnea.
• Patient and Family Education: Education was provided regarding disease process, inhaler technique, smoking cessation, avoidance of dust and smoke, breathing exercises, medication adherence, vaccination, nutrition, and early warning signs requiring hospital visit.

HEALTH EDUCATION

• Smoking Cessation: Patient was educated that complete smoking cessation is the most important step to slow disease progression. Even one cigarette can worsen airway inflammation and increase exacerbation risk. Family members were also advised not to smoke inside the house.
• Inhaler Technique: Patient was taught correct inhaler use: shake inhaler, breathe out fully, place mouthpiece properly, press inhaler while breathing in slowly and deeply, hold breath for 10 seconds, then breathe out slowly. Spacer use was advised if coordination is poor.
• Breathing Exercises: Pursed-lip breathing and diaphragmatic breathing were demonstrated. Patient was advised to practice these exercises several times daily and during breathlessness.
• Airway Clearance: Patient was taught effective coughing and huff coughing to remove secretions without excessive fatigue. Adequate warm fluids were advised if not contraindicated.
• Trigger Avoidance: Patient was advised to avoid dust, smoke, strong perfumes, cold air, overcrowded places, and exposure to people with respiratory infections.
• Vaccination: Annual influenza vaccine and pneumococcal vaccination were advised as per physician recommendation to reduce risk of respiratory infections.
• Nutrition: Small frequent meals, high-protein foods, fruits, vegetables, and adequate fluids were advised. Heavy meals and gas-forming foods should be avoided.
• Follow-up: Regular follow-up with respiratory physician was advised. Spirometry, inhaler review, and oxygen requirement assessment should be done as recommended.
• Warning Signs: Patient and family were instructed to seek medical help immediately if breathlessness increases, sputum becomes yellow/green or blood-stained, fever develops, lips become blue, drowsiness/confusion occurs, or inhalers do not relieve symptoms.

PROGNOSIS

COPD is a chronic progressive disease, but symptoms and exacerbations can be controlled with proper treatment, smoking cessation, inhaler adherence, pulmonary rehabilitation, vaccination, nutrition, and avoidance of triggers. In this patient, prognosis is guarded because he has severe airflow limitation, recurrent exacerbations, long smoking history, occupational dust exposure, and Type II respiratory failure during admission. However, with strict smoking cessation, correct inhaler use, regular follow-up, pulmonary rehabilitation, and early treatment of infections, further decline can be slowed and quality of life can improve.

CONCLUSION

This case study presents Mr. Mohan Lal Sharma, a 68-year-old male with long-standing COPD who was admitted with acute exacerbation and Type II respiratory failure. The exacerbation was most likely triggered by respiratory infection, as evidenced by fever, purulent sputum, raised WBC count, and worsening dyspnea. He required controlled oxygen therapy, nebulized bronchodilators, corticosteroids, antibiotics, chest physiotherapy, and non-invasive ventilation support.

The case highlights the essential role of nurses in early recognition of respiratory distress, maintaining airway clearance, monitoring oxygen therapy, preventing CO₂ retention, administering nebulization and medications, supporting NIV, reducing anxiety, conserving energy, improving nutrition, and providing long-term education. COPD care does not end at discharge; it requires lifelong self-management and family support.

The most important nursing responsibility in this case is to educate the patient and family regarding smoking cessation, inhaler technique, breathing exercises, infection prevention, nutrition, follow-up, and warning signs of exacerbation. With consistent care and adherence to treatment, the patient can reduce hospital admissions and maintain better functional capacity.

📄 Page 13 — NANDA Nursing Diagnoses

📄 Page 14-16 — Nursing Care Plans (NANDA Format)

Nursing Care Plan — 1: Ineffective Airway Clearance

Nursing Care Plan — 2: Impaired Gas Exchange

Nursing Care Plan — 3: Ineffective Breathing Pattern

📄 Page 17 — Discharge Summary

Mr. Mohan Lal Sharma, 68-year-old male, was admitted to Mathura Das Mathur Hospital, Jodhpur on 10/03/2026 at 9:15 PM with severe breathlessness, productive cough with thick yellow sputum, wheezing, fever, chest tightness, and drowsiness. He was a known case of COPD for 8 years with long history of smoking and occupational exposure to textile dust. On admission, he was tachypneic, hypoxic, cyanosed, and using accessory muscles of respiration. SpO₂ was 82% on room air. ABG showed pH 7.31, PaCO₂ 62 mmHg, PaO₂ 54 mmHg, suggestive of acute exacerbation of COPD with Type II respiratory failure.

During hospitalization, the patient was managed with controlled oxygen therapy, non-invasive ventilation/BiPAP support, nebulized bronchodilators, IV corticosteroids, antibiotics, antipyretics, chest physiotherapy, breathing exercises, nutritional support, and close monitoring of respiratory status. His condition improved gradually. Fever subsided, sputum became less purulent, wheezing reduced, oxygen saturation improved, and respiratory distress decreased.

At discharge, patient is conscious, oriented, afebrile, hemodynamically stable, and able to maintain SpO₂ around 94% on room air/low-flow oxygen as advised. Respiratory rate reduced to 20/min. Patient is able to walk short distances with mild exertional dyspnea. He and his family were educated regarding inhaler technique, smoking cessation, breathing exercises, nutrition, trigger avoidance, vaccination, and follow-up care.

At discharge, the patient is advised to:

• Stop smoking completely and permanently; avoid passive smoke exposure.
• Use inhalers exactly as prescribed and demonstrate correct inhaler technique at every follow-up.
• Practice pursed-lip breathing and diaphragmatic breathing daily.
• Continue steam inhalation or warm fluids if advised to loosen secretions.
• Take antibiotics, steroids, and bronchodilators only as prescribed; do not stop medicines suddenly.
• Avoid dust, smoke, strong perfumes, cold air, and crowded places during infection season.
• Maintain adequate nutrition with small frequent high-protein meals.
• Drink adequate fluids unless restricted by physician.
• Attend pulmonary rehabilitation or regular walking program as tolerated.
• Take annual influenza vaccination and pneumococcal vaccination as advised.
• Keep home environment clean, well ventilated, and smoke-free.
• Use mask while going outside in dusty areas.
• Follow up with respiratory physician after 1 week, then as advised.
• Seek immediate medical help if breathlessness increases, lips become blue, fever returns, sputum becomes green/yellow or blood-stained, confusion/drowsiness occurs, or inhalers do not relieve symptoms.

📄 Page 18 — Health Education

📄 Page 19 — Bibliography

1. Brunner, L.S. & Suddarth, D.S. (2022). Textbook of Medical-Surgical Nursing (15th ed.). Wolters Kluwer. Chapter: Management of Patients with Respiratory Disorders.
2. NANDA International. (2024). Nursing Diagnoses: Definitions and Classification 2024-2026 (13th ed.). Thieme Medical Publishers.
3. Lewis, S.L., Bucher, L., Heitkemper, M.M., Harding, M.M., Kwong, J., & Roberts, D. (2023). Medical-Surgical Nursing: Assessment and Management of Clinical Problems. Elsevier.
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2025). Global Strategy for the Diagnosis, Management, and Prevention of COPD.
5. World Health Organization. (2025). Chronic Obstructive Pulmonary Disease (COPD) — Fact Sheet. WHO, Geneva.
6. Hinkle, J.L. & Cheever, K.H. (2022). Brunner & Suddarth's Textbook of Medical-Surgical Nursing. Wolters Kluwer.
7. Doenges, M.E., Moorhouse, M.F., & Murr, A.C. (2024). Nursing Care Plans: Guidelines for Individualizing Client Care Across the Life Span. F.A. Davis Company.
8. Indian Chest Society & National College of Chest Physicians. COPD management guidelines and respiratory care recommendations.

© Nursing Study Vault | NANDA Format Case Study | Chronic Obstructive Pulmonary Disease (COPD)